Prescription drug prices are substantially higher in the United States than in other high-income countries, and as a result Americans spend more on prescription drugs than residents of other countries. Despite this, the government is not allowed to use its position as the largest purchaser of prescription drugs in the world (through Medicare Part D) to bargain for lower prices for patients. House Democrats have pledged to work on lowering prescription drug prices now that they are in the majority, including by allowing Medicare to negotiate prices, but it isn’t yet clear which bill they will bring to the floor to accomplish this.
Rep. Lloyd Doggett (D-TX) has introduced the Medicare Negotiation and Competitive Licensing Act (H.R. 1046) to give Medicare the power it needs to effectively negotiate with drug companies and bring drug prices down. Call your Representative (MoC) and tell them: reject bills that would use arbitration to bring down drug prices, and co-sponsor H.R. 1046, the Medicare Negotiation and Competitive Licensing Act!
In this resource, we’ll tell you more about how H.R. 1046 will bring drug prices down, explain why alternative proposals fall short, and provide you with the tools you need to tell your MoC to become a co-sponsor.